DCI is among the first in the nation to offer a targeted radiopharmaceutical therapy for men with advanced prostate cancer that's progressed on other treatments.
October is Breast Cancer Awareness Month. As with all types of cancer, early detection is the best defense against this disease that will affect about 1 in 8 women in the U.S.